Submission of Annual Report for the financial year 2024-2025 and Notice convening the 40th Annual General Meeting of the Company under Regulation 34 of the SEBI (Listing Obligations and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Link Pharma Chem Ltd has submitted its Annual Report for the financial year 2024-2025 to the stock exchanges. Along with the report, the company has also filed the Notice convening its 40th Annual General Meeting (AGM). The filing has been made under Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, which is a standard compliance requirement for listed companies. The Annual Report typically includes audited financial statements, the Board's report, auditor's report, and other statutory disclosures. The AGM Notice will contain details such as the date, time, and venue of the meeting, along with the agenda and any special resolutions to be considered by shareholders.
This is a routine regulatory filing and does not have a direct material impact on the stock price. Shareholders should review the Annual Report for details on the company's financial performance, business outlook, and any key proposals (such as dividend declaration, board appointments, or amendments) that will be voted on at the AGM.